Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome

Aerosol therapy in patients suffering from acute respiratory distress syndrome (ARDS) has so far failed in improving patients’ outcomes. This might be because dependent lung areas cannot be reached by conventional aerosols. Due to their physicochemical properties, semifluorinated alkanes (SFAs) could address this problem. After induction of ARDS, 26 pigs were randomized into three groups: (1) control (Sham), (2) perfluorohexyloctane (F6H8), and (3) F6H8-ibuprofen. Using a nebulization catheter, (2) received 1 mL/kg F6H8 while (3) received 1 mL/kg F6H8 with 6 mg/mL ibuprofen. Ibuprofen plasma and lung tissue concentration, bronchoalveolar lavage (BAL) fluid concentration of TNF-α, IL-8, and IL-6, and lung mechanics were measured. The ibuprofen concentration was equally distributed to the dependent parts of the right lungs. Pharmacokinetic data demonstrated systemic absorption of ibuprofen proofing a transport across the alveolo-capillary membrane. A significantly lower TNF-α concentration was observed in (2) and (3) when compared to the control group (1). There were no significant differences in IL-8 and IL-6 concentrations and lung mechanics. F6H8 aerosol seemed to be a suitable carrier for pulmonary drug delivery to dependent ARDS lung regions without having negative effects on lung mechanics.

[1]  A. Troxel,et al.  Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 , 2020, The New England journal of medicine.

[2]  F. Violi,et al.  Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge , 2020, Thrombosis and Haemostasis.

[3]  J. Marini,et al.  Management of COVID-19 Respiratory Distress. , 2020, JAMA.

[4]  J. Connors,et al.  Thromboinflammation and the hypercoagulability of COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[5]  S. Croubels,et al.  In Vivo Metabolism of Ibuprofen in Growing Conventional Pigs: A Pharmacokinetic Approach , 2019, Front. Pharmacol..

[6]  Z. Tong,et al.  Lung fluid biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis , 2019, Critical Care.

[7]  M. Ong,et al.  Extravascular lung water measurements in acute respiratory distress syndrome: why, how, and when? , 2018, Current opinion in critical care.

[8]  Jean G. Riess,et al.  Self-Organization of Semifluorinated Alkanes and Related Compounds at Interfaces: Thin Films, Surface Domains and Two-Dimensional Spherulites , 2018 .

[9]  Daniel Brodie,et al.  Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment , 2018, JAMA.

[10]  N. Islam,et al.  Formulation and delivery strategies of ibuprofen: challenges and opportunities , 2018, Drug development and industrial pharmacy.

[11]  Marina F Englesakis,et al.  Association of Driving Pressure With Mortality Among Ventilated Patients With Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis* , 2017, Critical care medicine.

[12]  M. Matthay,et al.  Inhalation therapies in acute respiratory distress syndrome. , 2017, Annals of translational medicine.

[13]  Laurent Brochard,et al.  Transpulmonary pressure: importance and limits. , 2017, Annals of translational medicine.

[14]  Ognjen Gajic,et al.  An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome , 2017, American journal of respiratory and critical care medicine.

[15]  V. Janout,et al.  Past and Present ARDS Mortality Rates: A Systematic Review , 2017, Respiratory Care.

[16]  W. Boemke,et al.  Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome (ARDS). , 2016, Journal of visualized experiments : JoVE.

[17]  T. Allen,et al.  Acute Lung Injury: A Clinical and Molecular Review. , 2016, Archives of pathology & laboratory medicine.

[18]  M. Kollef,et al.  The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysis. , 2015, Chest.

[19]  Arzu Ari.  Aerosol Therapy in Pulmonary Critical Care , 2015, Respiratory Care.

[20]  P. Pelosi,et al.  Open lung approach with low tidal volume mechanical ventilation attenuates lung injury in rats with massive brain damage , 2014, Critical Care.

[21]  Joseph C. Keenan,et al.  Lung recruitment in acute respiratory distress syndrome: what is the best strategy? , 2014, Current opinion in critical care.

[22]  M. Türk,et al.  Solubility of Ibuprofen, Phytosterol, Salicylic Acid, and Naproxen in Aqueous Solutions , 2013 .

[23]  Tilo Winkler,et al.  Lung physiology and aerosol deposition imaged with positron emission tomography. , 2013, Journal of aerosol medicine and pulmonary drug delivery.

[24]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[25]  B. Yard,et al.  Aerosolized semifluorinated alkanes as excipients are suitable for inhalative drug delivery--a pilot study. , 2012, International journal of pharmaceutics.

[26]  B. Yard,et al.  Semifluorinated alkanes--a new class of excipients suitable for pulmonary drug delivery. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  R. Rossaint,et al.  Semi-fluorinated alkanes as carriers for drug targeting in acute respiratory failure , 2010, Experimental lung research.

[28]  C. Guérin,et al.  Prone positioning improves survival in severe ARDS: a pathophysiologic review and individual patient meta-analysis. , 2010, Minerva anestesiologica.

[29]  J. Riess,et al.  Chemistry, physical chemistry, and uses of molecular fluorocarbon--hydrocarbon diblocks, triblocks, and related compounds--unique "apolar" components for self-assembled colloid and interface engineering. , 2009, Chemical reviews.

[30]  L. Ware.  Pathophysiology of acute lung injury and the acute respiratory distress syndrome. , 2006, Seminars in respiratory and critical care medicine.

[31]  Guillermo Bugedo,et al.  Lung recruitment in patients with the acute respiratory distress syndrome. , 2006, The New England journal of medicine.

[32]  Luciano Gattinoni,et al.  The concept of “baby lung” , 2005, Intensive Care Medicine.

[33]  Demosthenes Bouros,et al.  The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome , 2004, BMC pulmonary medicine.

[34]  J. Dötsch,et al.  Dose Response to Aerosolized Perflubron in a Neonatal Swine Model of Lung Injury , 2004, Pediatric Research.

[35]  R. Kuhn.  Pharmaceutical Considerations in Aerosol Drug Delivery , 2002, Pharmacotherapy.

[36]  J. Dötsch,et al.  Aerosolized Perfluorocarbon Suppresses Early Pulmonary Inflammatory Response in a Surfactant-Depleted Piglet Model , 2002, Pediatric Research.

[37]  F. Jardin.  Role of the heart in the loss of aeration characterizing lower lobes in acute respiratory distress syndrome. , 2001, American journal of respiratory and critical care medicine.

[38]  J. Dötsch,et al.  Persistent improvement of gas exchange and lung mechanics by aerosolized perfluorocarbon. , 2001, American journal of respiratory and critical care medicine.

[39]  J N Pritchard,et al.  The influence of lung deposition on clinical response. , 2001, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[40]  L. Puybasset,et al.  Role of the heart in the loss of aeration characterizing lower lobes in acute respiratory distress syndrome. CT Scan ARDS Study Group. , 2000, American journal of respiratory and critical care medicine.

[41]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[42]  N. Lois,et al.  Perfluorocarbons and Semifluorinated Alkanes , 2000, Seminars in ophthalmology.

[43]  H. Meinert,et al.  Semifluorinated Alkanes – A New Class of Compounds with Outstanding Properties for use in Ophthalmology , 2000, European journal of ophthalmology.

[44]  C. Biddle,et al.  Liquid ventilation innovations in ventilatory management. , 1998, AANA journal.

[45]  N. Davies,et al.  Clinical Pharmacokinetics of Ibuprofen , 1998, Clinical pharmacokinetics.

[46]  M. Quintel,et al.  [Liquid ventilation with perfluorocarbons]. , 1996, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS.

[47]  M R Wolfson,et al.  Liquid Ventilation Improves Pulmonary Function, Gas Exchange, and Lung Injury in a Model of Respiratory Failure , 1995, Annals of surgery.

[48]  P. Pelosi,et al.  Vertical gradient of regional lung inflation in adult respiratory distress syndrome. , 1994, American journal of respiratory and critical care medicine.

[49]  A. Jobe,et al.  Physiologic responses and distribution of aerosolized surfactant (Survanta) in a nonuniform pattern of lung injury. , 1993, The American review of respiratory disease.

[50]  A. Knoblich,et al.  The use of semifluorinated alkanes in blood-substitutes. , 1993, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.

[51]  G. Bernard,et al.  The role of cyclooxygenase products in lung injury induced by tumor necrosis factor in sheep. , 1992, The American review of respiratory disease.

[52]  A. Fowler,et al.  Delayed cyclo-oxygenase blockade reduces the neutrophil respiratory burst and plasma tumor necrosis factor levels in sepsis-induced acute lung injury. , 1991, The Journal of trauma.

[53]  L. Sansom,et al.  Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane production and the plasma unbound concentration of S(+)-ibuprofen. , 1991, British journal of clinical pharmacology.

[54]  M. Dahlbäck,et al.  Intrapulmonary deposition of aerosolized Evans blue dye and liposomes in an experimental porcine model of early ARDS. , 1990, Upsala journal of medical sciences.

[55]  W A Zin,et al.  A simple method for assessing the validity of the esophageal balloon technique. , 2015, The American review of respiratory disease.

[56]  A. Al-Jurf.  Positive end-expiratory pressure. , 1981, Surgery, gynecology & obstetrics.

[57]  T L Petty,et al.  Acute respiratory distress in adults. , 1967, Lancet.